These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4935316)

  • 1. Boticinogeny and actions of the bacteriocin.
    Anastasio KL; Soucheck JA; Sugiyama H
    J Bacteriol; 1971 Jul; 107(1):143-9. PubMed ID: 4935316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonistic effect on Clostridium botulinum type E by organisms resembling it.
    Kautter DA; Harmon SM; Lynt RK; Lilly T
    Appl Microbiol; 1966 Jul; 14(4):616-22. PubMed ID: 4288828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural changes in Clostridium botulinum type E after treatment with boticin S5 1 .
    Ellison JS; Mattern CF; Daniel WA
    J Bacteriol; 1971 Oct; 108(1):526-34. PubMed ID: 4107815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and some properties of two boticins.
    Ellison JS; Kautter JA
    J Bacteriol; 1970 Oct; 104(1):19-26. PubMed ID: 4919745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and properties of boticin P produced by Clostridium botulinum.
    Lau AH; Hawirko RZ; Chow CT
    Can J Microbiol; 1974 Mar; 20(3):385-90. PubMed ID: 4132521
    [No Abstract]   [Full Text] [Related]  

  • 6. Serological studies of Clostridium botulinum type E and related organisms. II. Serology of spores.
    Solomon HM; Lynt RK; Kautter DA; Lilly T
    J Bacteriol; 1969 May; 98(2):407-14. PubMed ID: 4891254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal growth temperature, sodium chloride tolerance, pH sensitivity, and toxin production of marine and terrestrial strains of Clostridium botulinum type C.
    Segner WP; Schmidt CF; Boltz JK
    Appl Microbiol; 1971 Dec; 22(6):1025-9. PubMed ID: 4944801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning, nucleotide sequence, and expression of the gene encoding the bacteriocin boticin B from Clostridium botulinum strain 213B.
    Dineen SS; Bradshaw M; Johnson EA
    Appl Environ Microbiol; 2000 Dec; 66(12):5480-3. PubMed ID: 11097932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competitive inhibition between different Clostridium botulinum types and strains.
    Eklund MW; Poysky FT; Peterson ME; Paranjpye RN; Pelroy GA
    J Food Prot; 2004 Dec; 67(12):2682-7. PubMed ID: 15633672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of nonproteolytic Clostridium botulinum with lactic acid bacteria and their bacteriocins at refrigeration temperatures.
    Rodgers S; Peiris P; Casadei G
    J Food Prot; 2003 Apr; 66(4):674-8. PubMed ID: 12696695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of media, additives, and incubation conditions on the recovery of high pressure and heat-injured Clostridium botulinum spores.
    Reddy NR; Tetzloff RC; Skinner GE
    Food Microbiol; 2010 Aug; 27(5):613-7. PubMed ID: 20510779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in spore germination response by strains of proteolytic Clostridium botulinum types A, B and F.
    Alberto F; Broussolle V; Mason DR; Carlin F; Peck MW
    Lett Appl Microbiol; 2003; 36(1):41-5. PubMed ID: 12485340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Clostridium botulinum by strains of Clostridium perfringens isolated from soil.
    Smith LD
    Appl Microbiol; 1975 Aug; 30(2):319-23. PubMed ID: 169734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriocin-mediated inhibition of Clostridium botulinum spores by lactic acid bacteria at refrigeration and abuse temperatures.
    Okereke A; Montville TJ
    Appl Environ Microbiol; 1991 Dec; 57(12):3423-8. PubMed ID: 1785919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine structure of protoplasts and L-forms of Clostridium botulinum types A and E.
    Brown GW; Pate JL; Sugiyama H
    J Bacteriol; 1971 Mar; 105(3):1207-10. PubMed ID: 4323294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic relationships among the proteolytic and nonproteolytic strains of Clostridium botulinum.
    Solomon HM; Lynt RK; Kautter DA; Lilly T
    Appl Microbiol; 1971 Feb; 21(2):295-9. PubMed ID: 4927406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for plasmid-mediated toxin and bacteriocin production in Clostridium botulinum type G.
    Eklund MW; Poysky FT; Mseitif LM; Strom MS
    Appl Environ Microbiol; 1988 Jun; 54(6):1405-8. PubMed ID: 2843093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observations on nonconverting phage, c-n71, obtained from a nontoxigenic strain of Clostridium botulinum type C.
    Oguma K; Iida H; Inoue K
    Jpn J Microbiol; 1975 Jun; 19(3):167-72. PubMed ID: 1100888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriocins of Clostridium perfringens. 1. Isolation and preliminary studies.
    Mahony DE; Butler ME
    Can J Microbiol; 1971 Jan; 17(1):1-6. PubMed ID: 4324544
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of a combined selection and enrichment PCR procedure for Clostridium botulinum Types B, E, and F and its use to determine prevalence in fecal samples from slaughtered pigs.
    Dahlenborg M; Borch E; Rådström P
    Appl Environ Microbiol; 2001 Oct; 67(10):4781-8. PubMed ID: 11571185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.